Muir-Torre Syndrome: case report and molecular characterization
Author
dc.contributor.author
Ríos del Prado, Carolina Alejandra
Author
dc.contributor.author
Villalón, Ricardo
es_CL
Author
dc.contributor.author
Muñoz, Jorge
es_CL
Author
dc.contributor.author
Acuña Patzke, Mónica
es_CL
Author
dc.contributor.author
Cifuentes Ovalle, Lucía
es_CL
Admission date
dc.date.accessioned
2014-12-12T14:03:53Z
Available date
dc.date.available
2014-12-12T14:03:53Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Sao Paulo Med J. 2014; 132(1):61-4
en_US
Identifier
dc.identifier.other
DOI: 10.1590/1516-3180.2014.1321634
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129361
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Muir-Torre syndrome is a rare autosomal dominant genodermatosis caused by mutations in
the mismatch repair genes. It is characterized by the presence of sebaceous skin tumors and internal malignancies,
affecting mainly the colon, rectum and urogenital tract. Awareness of this syndrome among
physicians can lead to early diagnosis of these malignancies and a better prognosis.
CASE REPORT: We report the case of a Chilean patient who, over the course of several years, had
multiple skin lesions, endometrial cancer and colon cancer. The syndrome was diagnosed using
molecular techniques such as microsatellite instability analysis, immunohistochemistry and DNA
sequencing, which allowed us to find the causative mutation.
CONCLUSION: Molecular diagnostics is a highly useful tool, since it allows clinicians to confirm
the presence of mutations causing Muir-Torre syndrome. It is complementary to the analysis of the
clinical data, such as dermatological presentation, presence of visceral malignancies and family
history of colorectal tumors, and it provides important knowledge to help physicians and patients
choose between treatment options.
en_US
Patrocinador
dc.description.sponsorship
Sources of funding: PhD fellowship from CONICYT AT-24080077 (to C.A.R.)